DelphX Announces the Issuance of Shares for Services
DelphX Capital Markets (TSXV: DELX) (OTCQB: DPXCF) announces the issuance of 428,571 common shares at a deemed price of C$0.14 per share to a consultant.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
DelphX Capital Markets (TSXV: DELX) (OTCQB: DPXCF) announces the issuance of 428,571 common shares at a deemed price of C$0.14 per share to a consultant. The shares, valued at C$60,000, are being issued as payment for services related to the Company's Credit Rating Security (CRS) product, including refinement of pricing models, preparation of presentations, and assistance with broker dealer negotiations. Following the issuance, which requires TSX Venture Exchange approval, DelphX will have 182,102,033 common shares outstanding.
Positive
- None.
Negative
- Share issuance will cause dilution to existing shareholders
- Company using shares instead of cash to pay for services, potentially indicating cash conservation needs
Details
News Market Reaction – DPXCF
The recorded move for DPXCF in the trading session of this news was -2.28%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Toronto, Ontario--(Newsfile Corp. - November 27, 2024) - DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF) ("DelphX" or the "Company"), a leader in the development of new classes of structured products for the fixed income market, announces that pursuant to an agreement with a consultant for services in connection with refining the pricing model for the Company's Credit Rating Security ("CRS") product, assisting in preparing presentations and materials for users of CRS, and assisting with the negotiation of terms and conditions with broker dealers on pricing of CRS, the Company will issue 428,571 common shares (the "Common Shares") to the consultant in satisfaction of the C
The Common Shares will be issued at a deemed price of
The issuance of Common Shares will not result in a new control person, and subsequent to the issuance, DelphX will have 182,102,033 common shares outstanding.
About DelphX Capital Markets Inc.
DelphX is a technology and financial services company focused on developing and distributing the next generation of structured products. Through its special purpose vehicle Quantem LLC, the Company enables fixed income dealers to offer new private placement securities that provide mitigation of spread and capital charge losses when downgrades occur, while allowing for attractive returns. The new DelphX securities will enable dealers and their qualified institutional investors (QIBs) accounts to competitively structure, sell and make markets in:
- Collateralized put options (CPOs) that provide secured rating downgrade protection for underlying corporate bonds;
- Collateralized reference notes (CRNs) that enable investors to take on a capped rating downgrade exposure of an underlying security in exchange for attractive returns.
All CPOs and CRNs are fully collateralized and held in custody by BNY Mellon. CPOs and CRNs are proprietary products created and owned by DelphX Capital Markets.
For more information about DelphX, please visit www.delphx.com.
George Wentworth, General Manager
DelphX Capital Markets Inc.
george.wentworth@delphx.com
(718) 509-2160
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/231722
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.